Similar articles

• [Schizophrenia as a dopamine excess syndrome].

  Toru M. Toru M. Nihon Rinsho. 1983 May;41(5):1021-7. Nihon Rinsho. 1983. PMID: 6138444 Review. Japanese. No abstract available.
• Implications of catecholamine systems of the brain in schizophrenia.

  Matthysse S. Matthysse S. Res Publ Assoc Res Nerv Ment Dis. 1974;53:305-15. Res Publ Assoc Res Nerv Ment Dis. 1974. PMID: 4155111 Review. No abstract available.
• [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].

  Anokhina IP, Gamaleia NB. Anokhina IP, et al. Zh Nevropatol Psikhiatr Im S S Korsakova. 1979;79(8):1096-1105. Zh Nevropatol Psikhiatr Im S S Korsakova. 1979. PMID: 384732 Review. Russian. No abstract available.
• [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].

  Lideman RR, Zlobina GP, Mukhin AG. Lideman RR, et al. Zh Nevropatol Psikhiatr Im S S Korsakova. 1980;80(5):762-9. Zh Nevropatol Psikhiatr Im S S Korsakova. 1980. PMID: 6106337 Review. Russian. No abstract available.
• Neuropsychopharmacology of monoamines and their regulatory enzymes.

  Lipton MA. Lipton MA. Adv Biochem Psychopharmacol. 1974;12(0):443-54. Adv Biochem Psychopharmacol. 1974. PMID: 4153941 No abstract available.